ESH-iCMLF 25th Annual John Goldman Conference on
Chronic Myeloid Leukemia: Biology and Therapy
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, François-Xavier Mahon, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

ESH-iCMLF 25th Annual John Goldman Conference on
Chronic Myeloid Leukemia: Biology and Therapy
Information
ABOUT THE CONFERENCE:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
This educational conference has been approved for 18 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!
SCIENTIFIC TOPICS:
• How I treat smoldering myeloma (SMM)
• How I treat newly diagnosed multiple myeloma
• From risk stratification to risk-based therapy?
• Should we use MRD testing to determine therapy in multiple myeloma?
• Is CAR T cell therapy replacing autologous SCT?
• How I treat relapsed multiple myeloma
• Cell free DNA / circulating tumor cells to replace BM-biopsy and MRD measurement
• You can’t be immune for immune therapy anymore
• The future of multiple myeloma
• Other plasma cell dyscrasias
Program
Read the final program!


